Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PX-12 in advanced pancreatic cancer
NCT00417287Phase 2Terminated
- Sponsor
- Cascadian Therapeutics
- Start
- Dec 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PX-12 in pancreatic carcinoma, sponsored by Cascadian Therapeutics. Started Dec 2006; status: terminated.
02
Drugs
PX-12
03
Conditions
pancreatic carcinoma
Beyond the preview
Go deeper on NCT00417287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00417287.